Innovations | Dana-Farber Cancer Institute
Dana-Farber Innovations is dedicated to advancing cancer research through groundbreaking technologies and collaborations. Learn about our research ...
Innovations \| Dana-Farber Cancer Institute[Skip to main content](#main-content)

- [Careers](https://careers.dana-farber.org/)
- [Contact Us](/contact)
- [Donate](https://danafarber.jimmyfund.org/site/Donation2?df_id=2100&mfc_pref=T&2100.donation=form1&utm_source=dfh&utm_medium=button&utm_campaign=AGDFH110123&s_src=AGDFH110123&s_subsrc=AGDFH110123)

[![DFCI Logo](https://dfci.widen.net/content/110ca04f-81c4-49f9-8e22-28a6ce5b3d0d/web/DFCI%20Logo%20Lens%20Color-rgb.svg)](/)

- [Find a Doctor](/find-a-doctor)
- [Appointments and Second Opinions](/appointments-second-opinions)
- [Find a Location](/locations)
- [Patient Portals](/patient-portals)

- [Cancer Types and Treatments](/cancer-care)














![nurse-practitioner-and-patient556x381.jpg](https://dfci.widen.net/content/ri9n147djk/web/nurse-practitioner-and-patient556x381.jpg?crop=yes&k=c&w=600&h=368&itok=d4Yi5_AR)





[**Care and Treatment**](/cancer-care)



Since 1947, Dana-Farber's sole focus has been to provide expert cancer care and groundbreaking treatments for adult and pediatric patients.















- [Cancer Types and Treatments](/cancer-care "Cancer Types and Treatments")

* * *

- [Cancer Types and Conditions We Treat](/cancer-care/types)

* * *


  - [Adult](/cancer-care/types?rows=10&fq=sm_age%3A%22adult%22)
  - [Pediatric](/cancer-care/types?rows=10&fq=sm_age%3A%22pediatric%22)
- [Treatment Centers and Clinical Services](/cancer-care/treatment)

* * *

- [Centers for Early Detection and Interception](/cancer-care/treatment/early-detection-interception)

* * *

- [Your Care Team](/cancer-care/care-team)

* * *

- [Clinical Trials](/research/clinical-trials)

* * *


- [For Patients and Families](/patient-family)














![healthy-raw-vegetables556x381.jpg](https://dfci.widen.net/content/htfmtrxnyd/web/healthy-raw-vegetables556x381.jpg?crop=yes&k=c&w=600&h=368&itok=IcqGg6fP)





[**Health Library**](/health-library)



Find information about cancer, treatments and procedures, symptom management, nutrition and diet, survivorship, and much more.















- [For Patients and Families](/patient-family "For Patients and Families")

* * *

- [Becoming Our Patient](/patient-family/becoming-our-patient)

* * *


  - [Insurance and Financial Information](/patient-family/becoming-our-patient/insurance-financial-information)
  - [Preparing for Your First Appointment](/patient-family/becoming-our-patient/first-appointment)
  - [Virtual Visits](/patient-family/becoming-our-patient/virtual-visits)
  - [Practical and Legal Matters](/patient-family/becoming-our-patient/practical-legal-matters)
  - [Patient Communications](/patient-family/becoming-our-patient/patient-communications)
- [Planning Your In-Person Visit](/patient-family/planning-your-visit)

* * *


  - [Prescreening and Mask Requirements](/patient-family/planning-your-visit/prescreening-mask-requirements)
  - [Outpatient Visitor Policy](/patient-family/planning-your-visit/outpatient-visitor-policy)
  - [Locations and Directions](/locations)
  - [Places to Stay](/patient-family/planning-your-visit/lodging)
  - [Places to Eat](/patient-family/planning-your-visit/dining)
- [COVID-19 Therapies and Vaccines for Patients](/patient-family/covid-19-therapies-and-vaccines-patients)

* * *

- [International Patients](/patient-family/international)

* * *

- [Support Services](/patient-family/support-services)

* * *

- [Patient Safety and Advocacy](/patient-family/safety-advocacy)

* * *

- [For Caregivers](/patient-family/caregivers)

* * *

- [For Cancer Survivors](/patient-family/survivors)

* * *

- [Cancer Prevention and Risk Reduction](/patient-family/cancer-prevention-risk)

* * *

- [Health Library](/health-library)

* * *


- [Research](/research)














![Maria-Luisa-Guerrera-Bing Center-Waldenströms-Macroglobulinemia](https://dfci.widen.net/content/oxtykuypie/web/Maria-Luisa-Guerrera-Bing%20Center-Waldenstr%C3%B6ms-Macroglobulinemia?crop=yes&k=c&w=600&h=368&itok=OQoc7eAo)





[Find Clinical Trials](/clinical-trials)



Search clinical trials for adult and pediatric cancers and blood disorders offered through Dana-Farber and our clinical partners.















- [Research](/research "Research")

* * *

- [Clinical Trials](/research/clinical-trials)

* * *

- [Departments, Centers, and Programs](/research/departments-centers)

* * *

- [Integrative Research Centers](/research/integrative-research)

* * *

- [Lab Websites](/research/labs)

* * *

- [Core Facilities](/research/core-facilities)

* * *

- [Innovations](/research/innovations)

* * *

- [Featured Research](/research/featured)

* * *

- [Our Researchers](/research/our-researchers)

* * *


- [For Physicians](/for-physicians)














![cpop-team](https://dfci.widen.net/content/f8qik7fbpb/web/cpop-team?crop=yes&k=c&w=600&h=368&itok=POlIPQUu)





[Refer a Patient](/refer)



For adult patients: [877-441-3324](tel:877-441-3324)

For pediatric patients: [888-733-4662](tel:888-733-4662)















- [For Physicians](/for-physicians "For Physicians")

* * *

- [Refer a Patient](/refer)

* * *

- [Transfer a Patient](/transfer)

* * *

- [Education and Training](/for-physicians/education-training)

* * *


  - [Continuing Medical Education](/for-physicians/education-training/continuing-medical-education)
  - [Fellowships and Training Programs](/for-physicians/education-training/fellowships-training-programs)
  - [Faculty Development](/for-physicians/education-training/faculty-development)
- [Clinical Resources](/for-physicians/clinical-resources)

* * *


  - [Cancer Diagnostic Service](/for-physicians/clinical-resources/cancer-diagnostic-service)
  - [For Hematologic Malignancies](/for-physicians/clinical-resources/hematologic-malignancies)
  - [For Stem Cell Transplant and Cellular Therapies](/for-physicians/clinical-resources/stem-cell-transplant-and-cellular-therapies)
- [Clinical Advances Hub](https://physicianresources.dana-farber.org/)

* * *

- [Physician Gateway](/for-physicians/physician-gateway)

* * *


- [How You Can Help](/how-you-can-help)














![hych-support-patients-600x368.jpg](https://dfci.widen.net/content/jizaussgnn/web/hych-support-patients-600x368.jpg?crop=yes&k=c&w=600&h=368&itok=YAc2euD3)





[Support the Jimmy Fund](https://www.jimmyfund.org/)



Make a donation or join an event to support Dana-Farber's mission.















- [How You Can Help](/how-you-can-help "How You Can Help")

* * *

- [Ways to Give](/how-you-can-help/ways-to-give)

* * *


  - [Memorial and Tribute Gifts](/how-you-can-help/ways-to-give/make-a-memorial-or-tribute-gift)
  - [Make a Recurring Gift](/how-you-can-help/ways-to-give/give-monthly)
  - [Naming and Funding Opportunities](/how-you-can-help/ways-to-give/naming-funding-opportunities)
  - [Tax-Efficient Gifts](/how-you-can-help/ways-to-give/tax-efficient-gifts)
  - [Corporate and Employee Giving](/how-you-can-help/ways-to-give/corporate-employee-giving)
  - [Foundation Giving](/how-you-can-help/ways-to-give/foundation-giving)
  - [Create Your Own Fundraising Page](/how-you-can-help/ways-to-give/create-your-own-fundraising-page)
  - [Giving Societies](/how-you-can-help/ways-to-give/giving-societies)
  - [Giving Day](/how-you-can-help/ways-to-give/giving-day)
  - [Bequests and Planned Gifts](https://danafarber.myplannedgift.org/)
- [Events](/how-you-can-help/events)

* * *


  - [Participate in a Fundraising Event](/how-you-can-help/events/participate)
  - [Support a Participant or Event](/how-you-can-help/events/support)
  - [Organize Your Own Fundraiser](/how-you-can-help/events/organize)
- [Get Involved](/how-you-can-help/get-involved)

* * *


  - [Corporate Engagement](/how-you-can-help/get-involved/corporate-engagement)
  - [Volunteer](/how-you-can-help/get-involved/volunteer)
  - [Friends of Dana-Farber](/how-you-can-help/get-involved/friends-dana-farber-cancer-institute)
  - [Donate Blood and Platelets](/how-you-can-help/get-involved/donate-blood-platelets)
  - [Donate Bone Marrow and Stem Cells](/how-you-can-help/get-involved/donate-bone-marrow-stem-cells)
  - [Behind the Breakthroughs](/how-you-can-help/get-involved/behind-the-breakthroughs)
  - [Legislative Action Network](/how-you-can-help/get-involved/legislative-action-network)
- [Shop](/how-you-can-help/shop)

* * *

- [Give Now](https://danafarber.jimmyfund.org/site/Donation2?df_id=2100&mfc_pref=T&2100_donation=form1&utm_source=dfh&utm_medium=button&utm_campaign=AGDFH110123&s_src=AGDFH110123&s_subsrc=AGDFH110123)

* * *


- [About Us](/about)














![kimmie-ng-and-patient556x381.jpg](https://dfci.widen.net/content/megjz0gzpk/web/kimmie-ng-and-patient556x381.jpg?crop=yes&k=c&w=600&h=368&itok=patrnNAo)





[**Why Choose Dana-Farber**](/about/why-dana-farber)



Each year, thousands of patients from around the world come to Dana-Farber for their cancer care. Find out why.















- [About Us](/about "About Us")

* * *

- [Mission and Values](/about/mission-values)

* * *

- [History](/about/history)

* * *

- [Leadership](/about/leadership)

* * *

- [Awards and Honors](/about/awards)

* * *

- [Newsroom and Publications](/newsroom)

* * *

- [Inclusion, Diversity, and Equity](/about/inclusion-diversity-equity)

* * *

- [Community Health](/community-health)

* * *

- [Global Health](/global-health)

* * *

- [Partners and Affiliates](/about/partners-affiliates)

* * *

- [Collaborations](/about/collaborations)

* * *

- [Proposed Future Cancer Hospital](/about/dana-farber-beth-israel-deaconess-cancer-collaboration)

* * *

- [Why Choose Dana-Farber](/about/why-dana-farber)

* * *

- [Quality and Patient Safety](/about/quality-safety)

* * *

- [Dana-Farber Direct Connect](/about/dana-farber-direct-connect)

* * *


[![DFCI Logo](https://dfci.widen.net/content/110ca04f-81c4-49f9-8e22-28a6ce5b3d0d/web/DFCI%20Logo%20Lens%20Color-rgb.svg)](/)

- [Find a Doctor](/find-a-doctor)
- [Appointments and Second Opinions](/appointments-second-opinions)
- [Find a Location](/locations)
- [Patient Portals](/patient-portals)

- [Careers](https://careers.dana-farber.org/)
- [Contact Us](/contact)
- [Donate](https://danafarber.jimmyfund.org/site/Donation2?df_id=2100&mfc_pref=T&2100.donation=form1&utm_source=dfh&utm_medium=button&utm_campaign=AGDFH110123&s_src=AGDFH110123&s_subsrc=AGDFH110123)

- [Research](https://www.dana-farber.org/research)

[Print](javascript:void(0)) [Email](mailto:?subject=Innovations - Dana-Farber Cancer Institute | Boston, MA &body=Check out this website: https://www.dana-farber.org/research/innovations)

# Robert and Renée Belfer Office for Dana-Farber Innovations

![innovation-3-1223x481.jpg](https://dfci.widen.net/content/rnvvvo8xro/web/innovation-3-1223x481.jpg?crop=yes&w=1223&h=481&itok=k8eaRVjQ)

[In this section](#1021395184-2257454937)

### Contact the Innovation Office

Belfer Office for Dana-Farber Innovations

10 Brookline Place, 3rd Floor

Brookline, MA 02445

**General Inquiry:** [innovation@dfci.harvard.edu](mailto:innovation@dfci.harvard.edu)

**Academic and/or Corporate MTAs:** [contractsteam@dfci.harvard.edu](mailto:contractsteam@dfci.harvard.edu)

Belfer Office for Dana-Farber Innovations

10 Brookline Place, 3rd Floor

Brookline, MA 02445

General Inquiry: [innovation@dfci.harvard.edu](mailto:https://www.dana-farber.org/research/core-facilities/ "innovation@dfci.harvard.edu")

Academic and/or Corporate MTAs: [contractsteam@dfci.harvard.edu](mailto:contractsteam@dfci.harvard.edu "contractsteam@dfci.harvard.edu")

## Innovations

### Our Mission

_To actively accelerate innovations to benefit patients, society, and the Dana-Farber Cancer Institute. We team with investigators to identify new discoveries and generate alliances to move science from bench to clinic for maximum impact._

### Our Vision

_To spark and fuel a spirit of innovation across the organization by providing effective tools to continuously question, create, and imagine what else might be possible._

### Collaboration Opportunities

In collaborating with Dana-Farber, your organization will have access to the Institute's specialized expertise, and to the unique array of core facilities needed to explore new areas of research. Learn more about [Dana-Farber Centers that are interested in partnering with industry](/research/integrative-research "Integrative Research Centers"). Explore [Dana-Farber's extensive Core Facilities](/research/core-facilities "Core Facilities"). And discover [more opportunities to collaborate](/research/innovations/collaboration "Collaboration Opportunities").

![bodfi-statistics-2021653x250.jpg](https://dfci.widen.net/content/97d91523-742b-4606-b0d9-e3119698cfa3/web/bodfi-statistics-2021653x250.jpg)

In partnership with the Innovation Office, Dana-Farber makes publicly available a list of FDA-approved therapeutics and diagnostics in which the Institute has a financial interest.

[View the list](/research/our-researchers/administration/innovations-disclosure "Disclosure of Dana-Farber Innovations")

## Technology News

![rani_george_sog_3564_09566x487.jpg](https://dfci.widen.net/content/9qcqejiaqm/web/rani_george_sog_3564_09566x487.jpg?crop=yes&k=c&w=600&h=368&itok=J6kZDum6)

[**Extracellular Domain Shedding of the ALK Receptor Mediates Neuroblastoma Cell Migration (Cell)**](https://www.cell.com/cell-reports/fulltext/S2211-1247%2821%2900761-0)

Although activating mutations of the anaplastic lymphoma kinase (ALK) membrane receptor occur in ∼10% of neuroblastoma (NB) tumors, the role of the wild-type (WT) receptor, which is aberrantly expressed in most non-mutated cases, is unclear. Both WT and mutant proteins undergo ECD cleavage. In a recent study published in Cell, first author, Hao Huang, PhD, and **senior author, Rani George, MD, PhD**, show that extracellular domain (ECD) cleavage of the ALK cell surface tyrosine kinase receptor mediates neuroblastoma cell migration through induction of an epithelial-to-mesenchymal transition (EMT) gene signature. They also show that ECD cleavage is caused by matrix metalloproteinase 9 (MMP-9), whose inhibition leads to decreased NB cell migration. Proteolytic cleavage of the ECD of WT ALK, which is expressed in most NB cases, promotes metastasis. By targeting that process, these adverse cancer-associated features of ALK cleavage can be circumvented, raising the possibility of MMP-9 inhibition, either singly or in combination with that of ALK in patients with NB ...

![eric-fischer566x487.jpg](https://dfci.widen.net/content/d8xfets1um/web/eric-fischer566x487.jpg?crop=yes&k=c&w=600&h=368&itok=zgBqK7IE)

[**Structure-Guided Design of a “Bump-and-Hole” Bromodomain-Based Degradation Tag (Journal of Medicinal Chemistry)**](https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00958)

Targeted protein degradation offers the potential for rapid and dose-dependent protein depletion through the use of protein fusion tags toward which protein degraders have been established. In a recent article published in the Journal of Medicinal Chemistry, first author Radoslaw Nowak, PhD, and **senior author Eric Fischer, PhD**, present a newly developed protein degradation tag BRD4BD1L94V along with the corresponding cereblon (CRBN)-based heterobifunctional degrader based on a “bump-and-hole” approach. The resulting compound XY-06-007 binds to BRD4BD1L94V with increased selectivity over the wild-type bromodomain, which translates into potent and preferential degradation of the degron tag. Nowak, Fisher, et al. anticipate that the BRD4BD1L94V degradation system can be used in tandem with other ligand-induced degradation tags to assess the synergistic effect of degrading multiple targets in a chemically controlled manner, enabling investigation into the consequences resulting from rapid degradation of previously undruggable disease codependencies ...

## Recent Research at Dana-Farber

![esmo-2024-v2.jpg](https://dfci.widen.net/content/opdvdkuciv/web/esmo-2024-v2.jpg?crop=yes&k=c&w=392&h=275&itok=v6Lpy_Ea)

News

9/11/2024

[Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024](https://www.dana-farber.org/newsroom/news-releases/2024/comprehensive-cancer-research-from-dana-farber-to-lead-esmo-congress-2024)

![Andrew Hantel 566x487.jpg](https://dfci.widen.net/content/w3kgniv4np/web/Andrew%20Hantel%20566x487.jpg?crop=yes&k=c&w=392&h=275&itok=7IFgm-Kb)

News

9/11/2024

[Criteria for cancer clinical trials and treatment regimens place patients of African and Middle Eastern ancestry at a disadvantage due to natural blood test variability, study finds](https://www.dana-farber.org/newsroom/news-releases/2024/criteria-for-cancer-clinical-trials-and-treatment-regimens-place-patients-of-african-and-middle-eastern-ancestry-at-a-disadvantage-due-to-natural-blood-test-variability-study-finds)

![](/sites/default/files/styles/card_392x275_/public/uploadedimages/expressreleases/Ann%2520Partridge%2520SO_05105_22-Edit%2520%281%29%281%29.jpg?itok=TF8RfvAA)

News

9/10/2024

[Ann Partridge receives 2024 ESMO Award for significant contributions to breast cancer research and patient care](https://www.dana-farber.org/newsroom/news-releases/2024/ann-partridge-receives-2024-esmo-award-for-significant-contributions-to-breast-cancer-research-and-patient-care)

![nicoletta-cieri-566x487.jpg](https://dfci.widen.net/content/ijnfyri2py/web/nicoletta-cieri-566x487.jpg?crop=yes&k=c&w=392&h=275&itok=F2B7GA1I)

News

9/4/2024

[New Research Offers Hope for Safer and More Effective Blood Stem Cell Transplants](https://www.dana-farber.org/newsroom/news-releases/2024/new-research-offers-hope-for-safer-and-more-effective-blood-stem-cell-transplants)

![dipanjan-chowdhury-566x487.jpg](https://dfci.widen.net/content/8qcrohgjry/web/dipanjan-chowdhury-566x487.jpg?crop=yes&k=c&w=392&h=275&itok=NjH2CNqy)

News

9/4/2024

[New research shows CDK5–cyclin B1 regulates mitotic fidelity](https://www.dana-farber.org/newsroom/news-releases/2024/new-research-shows-cdk5-cyclin-b1-regulates-mitotic-fidelity)

![Mariella-Filbin566x487.jpg](https://dfci.widen.net/content/31lonawll2/web/Mariella-Filbin566x487.jpg?crop=yes&k=c&w=392&h=275&itok=RYZg2KIC)

News

9/3/2024

[Adolescent Glioma Subtype Responds to CDK4/6 Inhibitor](https://www.dana-farber.org/newsroom/news-releases/2024/adolescent-glioma-subtype-responds-to-cdk46-inhibitor)

![ghobrial-syngal-odonnell-392xx275.jpg](https://dfci.widen.net/content/6ornclqhyu/web/ghobrial-syngal-odonnell-392xx275.jpg?crop=yes&k=c&w=392&h=275&itok=fmlaN4D6)

Publications

8/15/2024

[Early Action, Better Outcomes](https://www.dana-farber.org/newsroom/features/early-action-better-outcomes)

![Ellis_Reinherz657x753.jpg](https://dfci.widen.net/content/wwl6b426v0/web/Ellis_Reinherz657x753.jpg?crop=yes&k=c&w=392&h=275&itok=wVgKc_hN)

News

8/14/2024

[New Study Unveils the Power of Physical Forces in Enhancing T Cell Immune Response](https://www.dana-farber.org/newsroom/news-releases/2024/new-study-unveils-the-power-of-physical-forces-in-enhancing-t-cell-immune-response)

![Patrick-Wen-SOG_3866_19.jpg](https://dfci.widen.net/content/fccjrkyhtn/web/Patrick-Wen-SOG_3866_19.jpg?crop=yes&k=c&w=392&h=275&itok=NUesUniI)

News

8/6/2024

[FDA approves new therapy for glioma patients for first time in decades](https://www.dana-farber.org/newsroom/news-releases/2024/fda-approves-new-therapy-for-glioma-patients-for-first-time-in-decades)

## Get the help you need today.

- [Request an Appointment](/request-appointment)
- [Contact Us](/contact)

- [Clinical Trials](/research/clinical-trials)
- [Global Health](/global-health)
- [Inclusion, Diversity, and Equity](/about/inclusion-diversity-equity)
- [Community Health](/community-health)
- [Events](/events)

## Stay in touch with us

Discoveries, workshops, stories of hope and triumph can be found in the pages of Dana-Farber’s free digital newsletters and publications.

[Subscribe](/newsroom/newsletters)

Follow us on

- [ facebook](http://www.facebook.com/danafarbercancerinstitute)
- [ twitter](http://twitter.com/danafarber)
- [ linkedin](http://www.linkedin.com/company/dana-farber-cancer-institute)
- [ instagram](http://instagram.com/danafarber)
- [ youtube](http://www.youtube.com/user/DanaFarberCancerInst)

## About Dana-Farber

- [About Us](/about)
- [Our Mission](/about/mission-values)
- [Leadership](/about/leadership)
- [Awards](/about/awards)
- [History](/about/history)
- [Partners and Affiliates](/about/partners-affiliates)
- [Careers](https://careers.dana-farber.org/)

[About Dana-Farber](#3714045212-2469942478)

- [About Us](/about)
- [Our Mission](/about/mission-values)
- [Leadership](/about/leadership)
- [Awards](/about/awards)
- [History](/about/history)
- [Partners and Affiliates](/about/partners-affiliates)
- [Careers](https://careers.dana-farber.org/)

## Locations

- [Longwood](/locations/longwood)
- [Chestnut Hill](/locations/chestnut-hill)
- [Brighton](/locations/brighton)
- [Foxborough](/locations/foxborough)
- [Merrimack Valley](/locations/merrimack-valley)
- [Milford](/locations/milford)
- [Londonderry](/locations/londonderry)
- [South Shore](/locations/south-shore)

[Locations](#3714045212-1161590654)

- [Longwood](/locations/longwood)
- [Chestnut Hill](/locations/chestnut-hill)
- [Brighton](/locations/brighton)
- [Foxborough](/locations/foxborough)
- [Merrimack Valley](/locations/merrimack-valley)
- [Milford](/locations/milford)
- [Londonderry](/locations/londonderry)
- [South Shore](/locations/south-shore)

## Discovery and Insights

- [Newsroom](/newsroom)
- [Insight Blog](https://blog.dana-farber.org/insight/)
- [Newsletters](/newsroom/newsletters)
- [Publications](/newsroom/publications)
- [Podcasts](/health-library/unraveled)

[Discovery and Insights](#3714045212-2607699167)

- [Newsroom](/newsroom)
- [Insight Blog](https://blog.dana-farber.org/insight/)
- [Newsletters](/newsroom/newsletters)
- [Publications](/newsroom/publications)
- [Podcasts](/health-library/unraveled)

![](https://dfci.widen.net/content/b77baa3d-5752-4cb4-b5fa-a7a932a6d0bf/web/branded-main-nav-logo630x155.png)

450 Brookline Avenue, Boston, MA 02215

[617-632-3000](tel:617-632-3000)

![](https://dfci.widen.net/content/74dbf2d2-1d7d-42a1-ba0a-403d6a65b0e1/web/magnet_recognition_logo_pms_3278.png)![](https://dfci.widen.net/content/336fa306-616e-4ea9-8e39-7d6fdcd303eb/web/compcancercenter_v_rgb_color_badge.png)![](https://dfci.widen.net/content/f4982a29-b2d1-4858-acdc-41c69a51adcd/web/us-news-adult-badge-2024-2025-143x140.png)![](https://dfci.widen.net/content/fd625301-4c6c-457c-833e-ecb73ab1c1cb/web/us-news-pediatric-badge-2023-2024.png)![](https://dfci.widen.net/content/564abc40-3275-4121-b409-143db5df0262/web/nccn_logo_stacked-01.png)![](https://dfci.widen.net/content/ec46f092-0d9a-4bab-8c94-9d4f247e7095/web/hms-affiliate-logo-250.png)

- [Privacy Policy](/privacy-policy "Dana-Farber Informational Website Privacy Policy")
- [Terms of Use](/terms-of-use "These Terms of Use govern your use of our Sites.")
- [Accessibility](/accessibility "Dana-Farber Website Accessibility Statement")
- [Price Transparency](/patient-family/becoming-our-patient/insurance-financial-information/charges)

Copyright © 2024 Dana-Farber Cancer Institute, Inc. All Rights Reserved.